WallStreetZenWallStreetZen

AnalystsEmily Bodnar
Emily Bodnar's Stock Forecasts

Analyst Ranking
Bottom 13%
#3701 out of 4237 analysts
Average Return
-3.03%
Win Rate
44%21 out of 48
Risk vs Reward
Poor
Good

Emily Bodnar's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Dice Therapeutics IncDICE
+86.99%$16.06$30.03
2022-07-18 -
2023-06-02
Buy
Ventyx Biosciences IncVTYX
+54.62%$21.99$34.00
2022-09-01 -
2023-06-02
Buy
Olema Pharmaceuticals IncOLMA
+45.76%$3.89$5.67
2023-03-10 -
2023-06-02
Buy
Gracell Biotechnologies IncGRCL
+45.71%$2.10$3.06
2023-02-16 -
2023-06-02
Buy
Arcellx IncACLX
+38.22%$30.38$41.99
2023-02-13 -
2023-06-02
Buy

Emily Bodnar Analyst Color

Get additional color on Emily Bodnar's coverage of popular stocks

Emily Bodnar's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Gracell Biotechnologies IncGRCL
4Buy$12.00+292.16%Reiterates
9 days ago
Purple Biotech LtdPPBT
3Buy$7.00+319.16%Reiterates
18 days ago
Mink Therapeutics IncINKT
4Buy$10.00+446.45%Maintains
23 days ago
Imunon IncIMNN
2Buy$12.00+860.00%Reiterates
23 days ago
Dice Therapeutics IncDICE
6Buy$60.00+99.80%Reiterates
23 days ago
Ventyx Biosciences IncVTYX
4Buy$54.00+58.82%Reiterates
23 days ago
Olema Pharmaceuticals IncOLMA
4Buy$17.00+199.82%Maintains
23 days ago
Arcellx IncACLX
3Buy$49.00+16.69%Maintains
a month ago
Novocure LtdNVCR
3Buy$115.00+44.62%Maintains
a month ago
Acrivon Therapeutics IncACRV
2Buy$24.00+94.02%Reiterates
a month ago
Nkarta IncNKTX
2Buy$30.00+531.58%Maintains
3 months ago
Io Biotech IncIOBT
2Buy$10.00+395.05%Reiterates
3 months ago
Agenus IncAGEN
1Buy$8.00+400.00%Assumes
3 months ago
Briacell Therapeutics CorpBCTX
2Buy$25.00+305.19%Reiterates
3 months ago
Context Therapeutics IncCNTX
2Buy$4.00+212.50%Reiterates
4 months ago
Sqz Biotechnologies CoSQZ
2HoldN/AN/ADowngrades
6 months ago
Transcode Therapeutics IncRNAZ
2Buy$120.00+2,937.97%Maintains
7 months ago
Femasys IncFEMY
2Buy$5.00+584.93%Maintains
7 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.